Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myeloid leukemia after hematotoxins.

Environmental health perspectives - 1 Dec 1996

Larson R A, LeBeau M M, Vardiman J W, Rowley J D

Abstract excerpt

One of the most serious consequences of cancer therapy is the development of a second cancer, especially leukemia. Several distinct subsets of therapy-related leukemia can now be distinguished. Classic therapy-related myeloid leukemia typically occurs 5 to 7 years after exposure to alkylating age...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Chromosomes, Human, Pair 11
Share to Chromosomes, Human, Pair 21

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid

Share to Mutation

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Time Factors

Share to Translocation, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 9118910
DOI: 10.1289/ehp.961041303
PMCID: PMC1469761

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-9118910-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myeloid leukemia after hematotoxins.PMID 9118910Read ↗

PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASMSemantic proximity Read ↗

Therapy-related myeloid leukemia.Semantic proximity Read ↗

Therapy Related Leukemias: Susceptibility, Prevention and TreatmentSemantic proximity Read ↗

Etiology and Management of Therapy-Related Myeloid LeukemiaSemantic proximity Read ↗

Therapy-related myelodysplasia and acute myeloid leukemia.Semantic proximity Read ↗

Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)—multiple rather than a single mechanismSemantic proximity Read ↗

Therapy-related myeloid neoplasms: when genetics and environment collide.Semantic proximity Read ↗

TOPOISOMERASE II INHIBITOR‐RELATED ACUTE MYELOID LEUKAEMIASemantic proximity Read ↗

Novel therapeutic strategies for MLL-rearranged leukemias.Semantic proximity Read ↗

Therapy-Related Myeloid NeoplasmsSemantic proximity Read ↗

Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?Semantic proximity Read ↗

Therapy-related acute myeloid leukemia–like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.